A delay in the FDA decision for NT-501 could leave those with macular telangiectasia (MacTel) without any form of treatment ...

Timely care and support help HIV patients reach a zero-transmission goal. Harris Health's READI program shows how to manage ...

The global burden of diabetes and untreated diabetes increased from 1990 to 2022, according to a study published onlin ...

GLP-1 drug shortages, driven by cosmetic and weight loss purposes, result in access disparities among individuals with ...

An advancement in diabetes treatment has been achieved by Professor Hyun-Wook Kang and his team from the Department of ...

Stavros Nicolaou from Aspen Pharma Group agreed that investment is needed to avoid another pandemic. He spoke mostly on ...

Kano State Commissioner of Health, Dr Abubakar Yusuf, has stated that diabetes can be treated and its consequences can be ...

A recent study from the Federal University of São Paulo (UNIFESP) has found that using infrared light along with regular ...

The following is a summary of "Adherence and persistence among people with type 2 diabetes newly initiating oral semaglutide ...

Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...

LONDON – Global diabetes rate in adults has doubled over the past three decades, impacting more than 800 million people ...

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with ...